For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size

ATLANTA, March 31, 2019 /PRNewswire/ -- Combining immunotherapy with chemotherapy shows promise for treating advanced pancreatic cancer, shrinking tumors in a majority of evaluable patients – 20 out of 24 – as of an interim analysis of phase 1b data from an ongoing trial. The findings are ...

from PR Newswire: https://ift.tt/2CL6Kfx